euroPLX 71 2019 Lisbon
The online interaction and matchmaking systems of euroPLX Conferences provide 25 to 30 pre-arranged business meetings per attending company. It is the preferred partnering platform for new business opportunities since 24 years. Information exchange and interaction between confirmed registrants starts right after registration, intensifying during the month before the conference with two days of targeted, pre-scheduled one-on-one meetings of top executives of drug developing, producing or marketing companies from all over the world.
The partnering scope ranges from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution. The "Dynamic Partnering Focus" of this conference shows up on this page as soon as a sufficient number of collaboration interests are submitted.
In addition, attending companies may offer or look for R&D services, supporting technologies (e.g. new drug delivery), contract manufacture, and the supply of APIs and intermediates.